Risky assets jump on another vaccine news
Stock markets experienced a big jump while gold plunged after Moderna announced results of the interim analysis of phase 3 trial of its coronavirus vaccine. Moderna said that its vaccine has shown 94.5% efficiency. This is higher than 90% efficiency of the Pfizer/BioNTech vaccine announced last week. Analysis has met required statistical criteria. Vaccine developed by Moderna can also be stored for longer than one from Pfizer making logistics easier. Company plans to file for an emergency use authorization in the United States in the coming weeks.
Markets seem to like the news with a big boost to riskier assets. DE30 jumped 100 points on the news while US500 gained around 20 points. Gold slumped around $25 and USDJPY jumped from 104.50 to 105.00.
Start investing today or test a free demo
Create account Try a demo Download mobile app Download mobile app
DE30 tests resistance zone at 13,250 pts following announcement from Moderna. Source: xStation5This content has been created by XTB S.A. This service is provided by XTB S.A., with its registered office in Warsaw, at Prosta 67, 00-838 Warsaw, Poland, entered in the register of entrepreneurs of the National Court Register (Krajowy Rejestr Sądowy) conducted by District Court for the Capital City of Warsaw, XII Commercial Division of the National Court Register under KRS number 0000217580, REGON number 015803782 and Tax Identification Number (NIP) 527-24-43-955, with the fully paid up share capital in the amount of PLN 5.869.181,75. XTB S.A. conducts brokerage activities on the basis of the license granted by Polish Securities and Exchange Commission on 8th November 2005 No. DDM-M-4021-57-1/2005 and is supervised by Polish Supervision Authority.
